RecruitingACTRN12624001193561

Effect of Red Light on Performance in Trained Rowers

The effect of red and near-infrared light on exercise performance in rowers


Sponsor

University of Waikato

Enrollment

16 participants

Start Date

Aug 19, 2024

Study Type

Interventional

Conditions

Summary

Evidence suggests that phototherapy via red/infra-red light applied directly to the muscle has the potential to enhance various aspects of sports performance with a proposed mechanism that includes increased mitochondrial respiration. A systematic review concluded that phototherapy consistently provided an ergogenic effect on skeletal muscle (Borsa et al., 2013). Participants will be asked to attend four exercise sessions at a University of sports laboratory where they will be exposed to either red light (630 & 660 nm), infra-red light (810, 830, and, 850 nm), combined red and infra-red light, or a placebo from a commercially available portable phototherapy device (SOHL® Complete) for 5 minutes before a submaximal effort to assess the impact on oxygen uptake. We hypothesize that short-duration exposure to specific wavelengths of light will improve aerobic fitness


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 30 Yearss

Plain Language Summary

Simplified for easier understanding

Red and near-infrared light therapy (photobiomodulation) involves shining specific wavelengths of light directly onto muscles, and growing evidence suggests it may boost energy production in muscle cells and improve athletic performance. This study is testing whether a brief 5-minute exposure to different wavelengths of light before exercise can improve oxygen use (aerobic efficiency) in trained rowers. Participants will attend four lab sessions, each time receiving a different type of light (red only, infrared only, combined red and infrared, or placebo/no active light) before performing a submaximal rowing test. Oxygen uptake and performance measures will be recorded for each condition. You may be eligible if you are a trained rower aged 18 to 30 with no history of photosensitivity and no injury that would affect your rowing. There are no other exclusion criteria. This is a low-risk study that could contribute to understanding a novel and non-invasive way to support athletic performance and recovery.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Participants will be asked to attend four exercise sessions at a University of sports laboratory where they will be exposed to either red light (630 & 660 nm), infra-red light (810, 830, and, 850 nm),

Participants will be asked to attend four exercise sessions at a University of sports laboratory where they will be exposed to either red light (630 & 660 nm), infra-red light (810, 830, and, 850 nm), combined red and infra-red light, or a placebo (device turned on, but paused so no light is emitted), The light will be delivered with participants standing in front of the phototherapy device (SOHL® Complete) at a distance of 30 cm for 5 minutes, A researcher will accompany the participant into a private, windowless room in a University of Waikato campus laboratory. They will give instructions to the participant, position them in front of the phototherapy device, and provide them with the eye-protection. Adherence will be assessed verbally during and after the intervention. Participants will be exposed to one of either red light (630 & 660 nm), infra-red light (810, 830, and 850 nm), combined red and infra-red light (630 & 660, 810, 830, and 850 nm), or a placebo in a randomised order during the four separate visits to the laboratory. Immediately after the light exposure, the participants will perform 7, 3 minute submaximal exercise bouts on a rowing ergometer. Each bout of submaximal exercise will be separated by 2 minutes rest and each visit to the laboratory will be separated by at least 3 days.


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12624001193561


Related Trials